Linear Regression Model for Cancer Treatment Response Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a unified global approach to identify patients most likely to benefit from specific treatments, with limited clinically used predictive biomarkers, especially in cancer treatment, leading to inefficiencies in treatment response prediction.
Innovation Solution
Development of linear regression predictor models that determine gene expression levels and mutation statuses to predict treatment responses using Elastic-Net regression, incorporating data from databases like the Genomics of Drug Sensitivity in Cancer, allowing for personalized treatment selection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple separate predictive biomarkers are used to identify patients likely to benefit from specific treatments, then treatment response prediction accuracy may improve, but the complexity of clinical implementation and model integration increases
Solution Approach 1:
The patent combines multiple predictive biomarkers (gene expression levels and mutation statuses) into a single unified linear regression model that outputs a treatment-response score. This merging approach integrates multiple data sources while maintaining clinical usability through a single predictive framework.
Solution Approach 2:
The linear regression model serves multiple functions: it integrates diverse biomarker data types (expression and mutation), predicts treatment response across different cancer types, and provides a standardized scoring system that can be applied universally to various therapeutic contexts.
2Productivity
If a unified global approach for identifying patients likely to benefit from treatments is developed, then clinical benefit and treatment selection efficiency improve, but the complexity of data integration and model development increases
Solution Approach 1:
The model segments the complex task of treatment prediction into distinct input components (gene expression levels and mutation statuses) that are processed separately through the linear regression framework, allowing for systematic data integration while maintaining overall model simplicity.
Solution Approach 2:
The patent transforms diverse biological data types (gene expression continuous values and mutation categorical data) into a unified predictive framework by applying appropriate parameter transformations and scaling, enabling efficient integration without losing information from either data type.
3Reliability
If limited clinically used predictive biomarkers are used, then model simplicity is maintained, but the ability to identify patients who will respond to treatments is insufficient
Solution Approach 1:
The patent performs preliminary selection and validation of biomarkers using training datasets before clinical application. This preliminary action ensures that only the most predictive biomarkers are included in the final model, optimizing patient response identification while controlling the number of biomarkers used.
Data Source
AI summary
Methods of generating linear regression predictor models capable of predicting responses of patients afflicted with diseases to treatments, methods of using the linear regression predictor models to predict the responses of the patients to the treatments, and methods of administering the treatments to the patients.